Cidara Therapeutics
CDTX
CDTX
42 hedge funds and large institutions have $90M invested in Cidara Therapeutics in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
22% less funds holding
Funds holding: 54 → 42 (-12)
92% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 13
Holders
42
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$2.04M | |
| 2 | +$1.88M | |
| 3 | +$1.16M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$203K |
| 5 |
Squarepoint
New York
|
+$167K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$650K | |
| 3 | -$492K | |
| 4 |
PA
Perceptive Advisors
New York
|
-$465K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$353K |